Exercise during and after neoadjuvant rectal cancer treatment (the EXERT trial): study protocol for a randomized controlled trial

Exercise during and after neoadjuvant rectal cancer treatment (the EXERT trial): study protocol for a randomized controlled trial

Abstract Background Standard treatment for locally advanced rectal cancer includes 5–6 weeks of neoadjuvant chemoradiotherapy (NACRT) followed by total mesorectal excision 6–8 weeks later. NACRT improves local disease control and surgical outcomes but also causes side effects including fatigue, diar...

Full description

Bibliographic Details
Main Authors: Andria R. Morielli, Nawaid Usmani, Normand G. Boulé, Diane Severin, Keith Tankel, Tirath Nijjar, Kurian Joseph, Alysa Fairchild, Kerry S. Courneya
Format: Article
Language:English
Published: BMC 2018-01-01
Series:Trials
Subjects:
Exercise
Cancer
Symptom management
Quality of life
Physical fitness
Physical activity
Online Access:http://link.springer.com/article/10.1186/s13063-017-2398-1

Internet

http://link.springer.com/article/10.1186/s13063-017-2398-1

Similar Items